Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell Transplantation.
Identifieur interne : 000A51 ( PubMed/Curation ); précédent : 000A50; suivant : 000A52Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell Transplantation.
Auteurs : Michelle K. Yong ; Paul U. Cameron ; Monica Slavin ; C Orla Morrissey ; Krystal Bergin ; Andrew Spencer ; David Ritchie ; Allen C. Cheng ; Assia Samri ; Guislaine Carcelain ; Brigitte Autran ; Sharon R. LewinSource :
- The Journal of infectious diseases [ 1537-6613 ] ; 2017.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Cytomegalovirus (immunologie), Facteur de nécrose tumorale alpha (analyse), Facteur de nécrose tumorale alpha (métabolisme), Femelle, Humains, Infections à cytomégalovirus (diagnostic), Infections à cytomégalovirus (immunologie), Interféron gamma (analyse), Interféron gamma (métabolisme), Jeune adulte, Lymphocytes T (immunologie), Mâle, Sujet immunodéprimé (immunologie), Sujet âgé, Tests de libération d'interféron-gamma (), Transplantation de cellules souches hématopoïétiques (effets indésirables), Valeur prédictive des tests, Études longitudinales, Études prospectives.
- MESH :
- analyse : Facteur de nécrose tumorale alpha, Interféron gamma.
- diagnostic : Infections à cytomégalovirus.
- effets indésirables : Transplantation de cellules souches hématopoïétiques.
- immunologie : Cytomegalovirus, Infections à cytomégalovirus, Lymphocytes T, Sujet immunodéprimé.
- métabolisme : Facteur de nécrose tumorale alpha, Interféron gamma.
- Adolescent, Adulte, Adulte d'âge moyen, Femelle, Humains, Jeune adulte, Mâle, Sujet âgé, Tests de libération d'interféron-gamma, Valeur prédictive des tests, Études longitudinales, Études prospectives.
English descriptors
- KwdEn :
- Adolescent, Adult, Aged, Cytomegalovirus (immunology), Cytomegalovirus Infections (diagnosis), Cytomegalovirus Infections (immunology), Female, Hematopoietic Stem Cell Transplantation (adverse effects), Humans, Immunocompromised Host (immunology), Interferon-gamma (analysis), Interferon-gamma (metabolism), Interferon-gamma Release Tests (methods), Longitudinal Studies, Male, Middle Aged, Predictive Value of Tests, Prospective Studies, T-Lymphocytes (immunology), Tumor Necrosis Factor-alpha (analysis), Tumor Necrosis Factor-alpha (metabolism), Young Adult.
- MESH :
- chemical , analysis : Interferon-gamma, Tumor Necrosis Factor-alpha.
- adverse effects : Hematopoietic Stem Cell Transplantation.
- diagnosis : Cytomegalovirus Infections.
- immunology : Cytomegalovirus, Cytomegalovirus Infections, Immunocompromised Host, T-Lymphocytes.
- chemical , metabolism : Interferon-gamma, Tumor Necrosis Factor-alpha.
- methods : Interferon-gamma Release Tests.
- Adolescent, Adult, Aged, Female, Humans, Longitudinal Studies, Male, Middle Aged, Predictive Value of Tests, Prospective Studies, Young Adult.
Abstract
A simple test to identify recovery of CMV-specific T-cell immunity following hematopoietic stem cell transplantation (HSCT) could assist clinicians in managing CMV-related complications.
DOI: 10.1093/infdis/jix192
PubMed: 28431019
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000A54
Links to Exploration step
pubmed:28431019Curation
No country items
Michelle K. Yong<affiliation><nlm:affiliation>Department of Infectious Diseases, Monash University and Alfred Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">Monash University and Alfred Hospital</wicri:noCountry>
</affiliation>
<affiliation><nlm:affiliation>Department of Infectious Diseases, Monash University and Alfred Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">Monash University and Alfred Hospital</wicri:noCountry>
</affiliation>
<affiliation><nlm:affiliation>Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">University of Melbourne and Royal Melbourne Hospital</wicri:noCountry>
</affiliation>
<affiliation><nlm:affiliation>Department of Infectious Diseases, Monash University and Alfred Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">Monash University and Alfred Hospital</wicri:noCountry>
</affiliation>
<affiliation><nlm:affiliation>Department of Haematology, Monash University and Alfred Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">Monash University and Alfred Hospital</wicri:noCountry>
</affiliation>
<affiliation><nlm:affiliation>Department of Haematology, Monash University and Alfred Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">Monash University and Alfred Hospital</wicri:noCountry>
</affiliation>
<affiliation><nlm:affiliation>Department of Clinical Haematology and Bone Marrow Transplant Service, Royal Melbourne Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">Royal Melbourne Hospital</wicri:noCountry>
</affiliation>
<affiliation><nlm:affiliation>Department of Infectious Diseases, Monash University and Alfred Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">Monash University and Alfred Hospital</wicri:noCountry>
</affiliation>
<affiliation><nlm:affiliation>Institut National de la Sante et de la Recherche Medicale, U1135, Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Universités, University Pierre et Marie Curie.</nlm:affiliation>
<wicri:noCountry code="subField">University Pierre et Marie Curie</wicri:noCountry>
</affiliation>
<affiliation><nlm:affiliation>Institut National de la Sante et de la Recherche Medicale, U1135, Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Universités, University Pierre et Marie Curie.</nlm:affiliation>
<wicri:noCountry code="subField">University Pierre et Marie Curie</wicri:noCountry>
</affiliation>
<affiliation><nlm:affiliation>Institut National de la Sante et de la Recherche Medicale, U1135, Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Universités, University Pierre et Marie Curie.</nlm:affiliation>
<wicri:noCountry code="subField">University Pierre et Marie Curie</wicri:noCountry>
</affiliation>
<affiliation><nlm:affiliation>Department of Infectious Diseases, Monash University and Alfred Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">Monash University and Alfred Hospital</wicri:noCountry>
</affiliation>
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell Transplantation.</title>
<author><name sortKey="Yong, Michelle K" sort="Yong, Michelle K" uniqKey="Yong M" first="Michelle K" last="Yong">Michelle K. Yong</name>
<affiliation><nlm:affiliation>Department of Infectious Diseases, Monash University and Alfred Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">Monash University and Alfred Hospital</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Cameron, Paul U" sort="Cameron, Paul U" uniqKey="Cameron P" first="Paul U" last="Cameron">Paul U. Cameron</name>
<affiliation><nlm:affiliation>Department of Infectious Diseases, Monash University and Alfred Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">Monash University and Alfred Hospital</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Slavin, Monica" sort="Slavin, Monica" uniqKey="Slavin M" first="Monica" last="Slavin">Monica Slavin</name>
<affiliation><nlm:affiliation>Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">University of Melbourne and Royal Melbourne Hospital</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Morrissey, C Orla" sort="Morrissey, C Orla" uniqKey="Morrissey C" first="C Orla" last="Morrissey">C Orla Morrissey</name>
<affiliation><nlm:affiliation>Department of Infectious Diseases, Monash University and Alfred Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">Monash University and Alfred Hospital</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Bergin, Krystal" sort="Bergin, Krystal" uniqKey="Bergin K" first="Krystal" last="Bergin">Krystal Bergin</name>
<affiliation><nlm:affiliation>Department of Haematology, Monash University and Alfred Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">Monash University and Alfred Hospital</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Spencer, Andrew" sort="Spencer, Andrew" uniqKey="Spencer A" first="Andrew" last="Spencer">Andrew Spencer</name>
<affiliation><nlm:affiliation>Department of Haematology, Monash University and Alfred Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">Monash University and Alfred Hospital</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Ritchie, David" sort="Ritchie, David" uniqKey="Ritchie D" first="David" last="Ritchie">David Ritchie</name>
<affiliation><nlm:affiliation>Department of Clinical Haematology and Bone Marrow Transplant Service, Royal Melbourne Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">Royal Melbourne Hospital</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Cheng, Allen C" sort="Cheng, Allen C" uniqKey="Cheng A" first="Allen C" last="Cheng">Allen C. Cheng</name>
<affiliation><nlm:affiliation>Department of Infectious Diseases, Monash University and Alfred Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">Monash University and Alfred Hospital</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Samri, Assia" sort="Samri, Assia" uniqKey="Samri A" first="Assia" last="Samri">Assia Samri</name>
<affiliation><nlm:affiliation>Institut National de la Sante et de la Recherche Medicale, U1135, Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Universités, University Pierre et Marie Curie.</nlm:affiliation>
<wicri:noCountry code="subField">University Pierre et Marie Curie</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Carcelain, Guislaine" sort="Carcelain, Guislaine" uniqKey="Carcelain G" first="Guislaine" last="Carcelain">Guislaine Carcelain</name>
<affiliation><nlm:affiliation>Institut National de la Sante et de la Recherche Medicale, U1135, Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Universités, University Pierre et Marie Curie.</nlm:affiliation>
<wicri:noCountry code="subField">University Pierre et Marie Curie</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Autran, Brigitte" sort="Autran, Brigitte" uniqKey="Autran B" first="Brigitte" last="Autran">Brigitte Autran</name>
<affiliation><nlm:affiliation>Institut National de la Sante et de la Recherche Medicale, U1135, Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Universités, University Pierre et Marie Curie.</nlm:affiliation>
<wicri:noCountry code="subField">University Pierre et Marie Curie</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Lewin, Sharon R" sort="Lewin, Sharon R" uniqKey="Lewin S" first="Sharon R" last="Lewin">Sharon R. Lewin</name>
<affiliation><nlm:affiliation>Department of Infectious Diseases, Monash University and Alfred Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">Monash University and Alfred Hospital</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28431019</idno>
<idno type="pmid">28431019</idno>
<idno type="doi">10.1093/infdis/jix192</idno>
<idno type="wicri:Area/PubMed/Corpus">000A54</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000A54</idno>
<idno type="wicri:Area/PubMed/Curation">000A51</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000A51</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell Transplantation.</title>
<author><name sortKey="Yong, Michelle K" sort="Yong, Michelle K" uniqKey="Yong M" first="Michelle K" last="Yong">Michelle K. Yong</name>
<affiliation><nlm:affiliation>Department of Infectious Diseases, Monash University and Alfred Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">Monash University and Alfred Hospital</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Cameron, Paul U" sort="Cameron, Paul U" uniqKey="Cameron P" first="Paul U" last="Cameron">Paul U. Cameron</name>
<affiliation><nlm:affiliation>Department of Infectious Diseases, Monash University and Alfred Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">Monash University and Alfred Hospital</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Slavin, Monica" sort="Slavin, Monica" uniqKey="Slavin M" first="Monica" last="Slavin">Monica Slavin</name>
<affiliation><nlm:affiliation>Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">University of Melbourne and Royal Melbourne Hospital</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Morrissey, C Orla" sort="Morrissey, C Orla" uniqKey="Morrissey C" first="C Orla" last="Morrissey">C Orla Morrissey</name>
<affiliation><nlm:affiliation>Department of Infectious Diseases, Monash University and Alfred Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">Monash University and Alfred Hospital</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Bergin, Krystal" sort="Bergin, Krystal" uniqKey="Bergin K" first="Krystal" last="Bergin">Krystal Bergin</name>
<affiliation><nlm:affiliation>Department of Haematology, Monash University and Alfred Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">Monash University and Alfred Hospital</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Spencer, Andrew" sort="Spencer, Andrew" uniqKey="Spencer A" first="Andrew" last="Spencer">Andrew Spencer</name>
<affiliation><nlm:affiliation>Department of Haematology, Monash University and Alfred Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">Monash University and Alfred Hospital</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Ritchie, David" sort="Ritchie, David" uniqKey="Ritchie D" first="David" last="Ritchie">David Ritchie</name>
<affiliation><nlm:affiliation>Department of Clinical Haematology and Bone Marrow Transplant Service, Royal Melbourne Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">Royal Melbourne Hospital</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Cheng, Allen C" sort="Cheng, Allen C" uniqKey="Cheng A" first="Allen C" last="Cheng">Allen C. Cheng</name>
<affiliation><nlm:affiliation>Department of Infectious Diseases, Monash University and Alfred Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">Monash University and Alfred Hospital</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Samri, Assia" sort="Samri, Assia" uniqKey="Samri A" first="Assia" last="Samri">Assia Samri</name>
<affiliation><nlm:affiliation>Institut National de la Sante et de la Recherche Medicale, U1135, Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Universités, University Pierre et Marie Curie.</nlm:affiliation>
<wicri:noCountry code="subField">University Pierre et Marie Curie</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Carcelain, Guislaine" sort="Carcelain, Guislaine" uniqKey="Carcelain G" first="Guislaine" last="Carcelain">Guislaine Carcelain</name>
<affiliation><nlm:affiliation>Institut National de la Sante et de la Recherche Medicale, U1135, Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Universités, University Pierre et Marie Curie.</nlm:affiliation>
<wicri:noCountry code="subField">University Pierre et Marie Curie</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Autran, Brigitte" sort="Autran, Brigitte" uniqKey="Autran B" first="Brigitte" last="Autran">Brigitte Autran</name>
<affiliation><nlm:affiliation>Institut National de la Sante et de la Recherche Medicale, U1135, Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Universités, University Pierre et Marie Curie.</nlm:affiliation>
<wicri:noCountry code="subField">University Pierre et Marie Curie</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Lewin, Sharon R" sort="Lewin, Sharon R" uniqKey="Lewin S" first="Sharon R" last="Lewin">Sharon R. Lewin</name>
<affiliation><nlm:affiliation>Department of Infectious Diseases, Monash University and Alfred Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">Monash University and Alfred Hospital</wicri:noCountry>
</affiliation>
</author>
</analytic>
<series><title level="j">The Journal of infectious diseases</title>
<idno type="eISSN">1537-6613</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Cytomegalovirus (immunology)</term>
<term>Cytomegalovirus Infections (diagnosis)</term>
<term>Cytomegalovirus Infections (immunology)</term>
<term>Female</term>
<term>Hematopoietic Stem Cell Transplantation (adverse effects)</term>
<term>Humans</term>
<term>Immunocompromised Host (immunology)</term>
<term>Interferon-gamma (analysis)</term>
<term>Interferon-gamma (metabolism)</term>
<term>Interferon-gamma Release Tests (methods)</term>
<term>Longitudinal Studies</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Predictive Value of Tests</term>
<term>Prospective Studies</term>
<term>T-Lymphocytes (immunology)</term>
<term>Tumor Necrosis Factor-alpha (analysis)</term>
<term>Tumor Necrosis Factor-alpha (metabolism)</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Cytomegalovirus (immunologie)</term>
<term>Facteur de nécrose tumorale alpha (analyse)</term>
<term>Facteur de nécrose tumorale alpha (métabolisme)</term>
<term>Femelle</term>
<term>Humains</term>
<term>Infections à cytomégalovirus (diagnostic)</term>
<term>Infections à cytomégalovirus (immunologie)</term>
<term>Interféron gamma (analyse)</term>
<term>Interféron gamma (métabolisme)</term>
<term>Jeune adulte</term>
<term>Lymphocytes T (immunologie)</term>
<term>Mâle</term>
<term>Sujet immunodéprimé (immunologie)</term>
<term>Sujet âgé</term>
<term>Tests de libération d'interféron-gamma ()</term>
<term>Transplantation de cellules souches hématopoïétiques (effets indésirables)</term>
<term>Valeur prédictive des tests</term>
<term>Études longitudinales</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Interferon-gamma</term>
<term>Tumor Necrosis Factor-alpha</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Hematopoietic Stem Cell Transplantation</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr"><term>Facteur de nécrose tumorale alpha</term>
<term>Interféron gamma</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Cytomegalovirus Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Infections à cytomégalovirus</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Transplantation de cellules souches hématopoïétiques</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Cytomegalovirus</term>
<term>Infections à cytomégalovirus</term>
<term>Lymphocytes T</term>
<term>Sujet immunodéprimé</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Cytomegalovirus</term>
<term>Cytomegalovirus Infections</term>
<term>Immunocompromised Host</term>
<term>T-Lymphocytes</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Interferon-gamma</term>
<term>Tumor Necrosis Factor-alpha</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Interferon-gamma Release Tests</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Facteur de nécrose tumorale alpha</term>
<term>Interféron gamma</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Female</term>
<term>Humans</term>
<term>Longitudinal Studies</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Predictive Value of Tests</term>
<term>Prospective Studies</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Sujet âgé</term>
<term>Tests de libération d'interféron-gamma</term>
<term>Valeur prédictive des tests</term>
<term>Études longitudinales</term>
<term>Études prospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A simple test to identify recovery of CMV-specific T-cell immunity following hematopoietic stem cell transplantation (HSCT) could assist clinicians in managing CMV-related complications.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28431019</PMID>
<DateCreated><Year>2017</Year>
<Month>04</Month>
<Day>21</Day>
</DateCreated>
<DateCompleted><Year>2017</Year>
<Month>09</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>09</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1537-6613</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>215</Volume>
<Issue>11</Issue>
<PubDate><Year>2017</Year>
<Month>Jun</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of infectious diseases</Title>
<ISOAbbreviation>J. Infect. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell Transplantation.</ArticleTitle>
<Pagination><MedlinePgn>1684-1694</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1093/infdis/jix192</ELocationID>
<Abstract><AbstractText Label="Background" NlmCategory="UNASSIGNED">A simple test to identify recovery of CMV-specific T-cell immunity following hematopoietic stem cell transplantation (HSCT) could assist clinicians in managing CMV-related complications.</AbstractText>
<AbstractText Label="Methods" NlmCategory="UNASSIGNED">In an observational, multicenter, prospective study of 94 HSCT recipients we evaluated CMV-specific T-cell immunity at baseline, 3, 6, 9, and 12 months after transplant using the Quantiferon-CMV, an enzyme-linked immunosorbent spot assay (ELISpot), and intracellular cytokine staining.</AbstractText>
<AbstractText Label="Results" NlmCategory="UNASSIGNED">At 3 months after HSCT, participants who developed CMV disease (n = 8) compared with CMV reactivation (n = 26) or spontaneous viral control (n = 25) had significantly lower CD8+ T-cell production of interferon-γ (IFN-γ) in response to CMV antigens measured by Quantiferon-CMV (P = .0008). An indeterminate Quantiferon-CMV result had a positive predictive value of 83% and a negative predictive value of 98% for identifying participants at risk of further CMV reactivation. Participants experiencing CMV reactivation compared with patients without CMV reactivation had a reduced proportion of polyfunctional (IFN-γ+/tumor necrosis factor α-positive) CD4+ and CD8+ T cells and a higher proportion of interleukin 2-secreting cells (P = .01 and P = .002, respectively).</AbstractText>
<AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">Quantifying CMV-specific T-cell immunity after HSCT can identify participants at increased risk of clinically relevant CMV-related outcomes.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yong</LastName>
<ForeName>Michelle K</ForeName>
<Initials>MK</Initials>
<AffiliationInfo><Affiliation>Department of Infectious Diseases, Monash University and Alfred Hospital.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cameron</LastName>
<ForeName>Paul U</ForeName>
<Initials>PU</Initials>
<AffiliationInfo><Affiliation>Department of Infectious Diseases, Monash University and Alfred Hospital.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Slavin</LastName>
<ForeName>Monica</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Victorian Infectious Diseases Service, Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Peter MacCallum Cancer Centre.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Morrissey</LastName>
<ForeName>C Orla</ForeName>
<Initials>CO</Initials>
<AffiliationInfo><Affiliation>Department of Infectious Diseases, Monash University and Alfred Hospital.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Haematology, Monash University and Alfred Hospital.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bergin</LastName>
<ForeName>Krystal</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>Department of Haematology, Monash University and Alfred Hospital.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Spencer</LastName>
<ForeName>Andrew</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Haematology, Monash University and Alfred Hospital.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ritchie</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Department of Clinical Haematology and Bone Marrow Transplant Service, Royal Melbourne Hospital.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Medicine, University of Melbourne, Melbourne, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cheng</LastName>
<ForeName>Allen C</ForeName>
<Initials>AC</Initials>
<AffiliationInfo><Affiliation>Department of Infectious Diseases, Monash University and Alfred Hospital.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Samri</LastName>
<ForeName>Assia</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Institut National de la Sante et de la Recherche Medicale, U1135, Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Universités, University Pierre et Marie Curie.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Assistance Publique-Hopitaux de Paris, Hôpital Pitié-Salpêtrière, Département d'Immunologie, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Carcelain</LastName>
<ForeName>Guislaine</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Institut National de la Sante et de la Recherche Medicale, U1135, Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Universités, University Pierre et Marie Curie.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Assistance Publique-Hopitaux de Paris, Hôpital Pitié-Salpêtrière, Département d'Immunologie, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Autran</LastName>
<ForeName>Brigitte</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>Institut National de la Sante et de la Recherche Medicale, U1135, Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Universités, University Pierre et Marie Curie.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Assistance Publique-Hopitaux de Paris, Hôpital Pitié-Salpêtrière, Département d'Immunologie, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lewin</LastName>
<ForeName>Sharon R</ForeName>
<Initials>SR</Initials>
<AffiliationInfo><Affiliation>Department of Infectious Diseases, Monash University and Alfred Hospital.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Infect Dis</MedlineTA>
<NlmUniqueID>0413675</NlmUniqueID>
<ISSNLinking>0022-1899</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>82115-62-6</RegistryNumber>
<NameOfSubstance UI="D007371">Interferon-gamma</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003587" MajorTopicYN="N">Cytomegalovirus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003586" MajorTopicYN="N">Cytomegalovirus Infections</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018380" MajorTopicYN="N">Hematopoietic Stem Cell Transplantation</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016867" MajorTopicYN="N">Immunocompromised Host</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007371" MajorTopicYN="N">Interferon-gamma</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D059425" MajorTopicYN="N">Interferon-gamma Release Tests</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">T-cell immunity</Keyword>
<Keyword MajorTopicYN="N">cytomegalovirus</Keyword>
<Keyword MajorTopicYN="N">immunocompromised host</Keyword>
<Keyword MajorTopicYN="N">stem cell transplantation</Keyword>
<Keyword MajorTopicYN="N">viral immunity</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year>
<Month>4</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>9</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2017</Year>
<Month>4</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">28431019</ArticleId>
<ArticleId IdType="pii">3738528</ArticleId>
<ArticleId IdType="doi">10.1093/infdis/jix192</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A51 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000A51 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:28431019 |texte= Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell Transplantation. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:28431019" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a AustralieFrV1
This area was generated with Dilib version V0.6.33. |